{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T13:25:20Z","timestamp":1747142720439},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.7155","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T22:12:22Z","timestamp":1477951942000},"page":"3125-3129","source":"Crossref","is-referenced-by-count":11,"title":["A Rupture of a Lung Metastatic Lesion of Colon Cancer, Leading to Pneumothorax Caused by Bevacizumab"],"prefix":"10.2169","volume":"55","author":[{"given":"Tomoya","family":"Iida","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Otaru City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yabana","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Otaru City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Nakagaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Otaru City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeya","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Otaru City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Otaru City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611, 2004.","DOI":"10.1210\/er.2003-0027"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Ciln Oncol 23: 1011-1027, 2005.","DOI":"10.1200\/JCO.2005.06.081"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62, 2005.","DOI":"10.1126\/science.1104819"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Van CE, Rivera F, Berry S, et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20: 1842-1847, 2009.","DOI":"10.1093\/annonc\/mdp233"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm 66: 999-1013, 2009.","DOI":"10.2146\/ajhp080455"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated eith bevacizumab: a meta-analysis. Lancet Oncol 10: 559-568, 2009.","DOI":"10.1016\/S1470-2045(09)70112-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Verheul HM, Lolkema MP, Qian DZ, et al. Platelets take up the monoclonal antibody bevacizumab. Clin Cancer Res 13: 5341-5347, 2007.","DOI":"10.1158\/1078-0432.CCR-07-0847"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yanagihara K, Takei H, Iida S, et al. Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report. J Nippon Med Sch 81: 333-336, 2014.","DOI":"10.1272\/jnms.81.333"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ikeda S, Sekine A, Kato T, et al. Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case. Jpn J Clin Oncol 44: 497-500, 2014.","DOI":"10.1093\/jjco\/hyu023"},{"key":"10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","volume":"305","author":"V Ranpura","year":"2011","unstructured":"10. Ranpura V, Hapani S, Wu S. Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis. JAMA 305: 487-494, 2011.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yang SH, Lin JK, Chen WS, et al. Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol 41: 269-271, 2011.","DOI":"10.1093\/jjco\/hyq195"},{"key":"12","unstructured":"12. Tamura T, Tamura S, Nasu H, Fujimoto T, Kinoshita T. A case of intractable pneumothorax in a patient with pulmonary adenocarcinoma during bevacizumab-containing chemotherapy. Nihon Kokyuki Gakkai Zasshi 49: 702-706, 2011 (in Japanese, Abstract in English)."},{"key":"13","unstructured":"13. Zhang Y, Yang H, Zhao M, He J. Bilateral pneumothorax after bevacizumab-containing chemotherapy in fibrosarcoma. J Thorac Dis 4: 229-231, 2012."},{"key":"14","unstructured":"14. Makino T, Kudo S, Ogata T. Pneumothorax after treatment with bevacizumab-containing chemotherapy for breast cancer - a case report. Gan To Kagaku Ryoho 41: 233-235, 2014 (in Japanese, Abstract in English)."},{"key":"15","unstructured":"15. Yamada N, Abe N, Usui K, et al. Clinical analysis of 12 cases of pneumothorax during intensive chemotherapy for malignant neoplasms. Gan To Kagaku Ryoho 37: 1519-1523, 2010 (in Japanese, Abstract in English)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fayda M, Kebudi R, Dizdar Y, et al. Spontaneous pneumothorax in children with osteosarcoma: report of three cases and review of the literature. Acta Chir Belg 112: 378-381, 2012.","DOI":"10.1080\/00015458.2012.11680856"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.7155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:28:47Z","timestamp":1498357727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.7155\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.7155","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}